This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Testicular germ cell tumours

Authoring team

Testicular germ cell cancer is mainly a disease of young men

  • 85% of cases are between the ages of 15 and 44 years (1)
  • life-time risk is around 1 in 200 in the UK (1)
  • If diagnosed early, 95% of cases can be cured and treatment can be less intensive (1)
  • between 90% and 95% of testicular cancers are germ cell tumours (GCTs) (2)
  • mean age at diagnosis for testicular cancer is 33 years (2)

Germ cell tumours are broadly divided into:

  • pure seminomas,
    • account for approximately 40% of tumours
  • non-seminomas
    • account for approximately 60% of tumours
    • include multiple cell types - e.g. embryonal cell carcinoma, choriocarcinoma, yolk sac tumour
    • clinically more aggressive (3)

Risk factors for testicular germ cell tumours include (2):

  • cryptorchidism
  • family history of testicular cancer
  • gonadal dysgenesis
  • infertility
  • cannabis use
  • genetic conditions such as Klinefelter syndrome

Initial presentation (4):

  • for about 90% of patients, a painless lump in the testicle is the initial symptom of testicular cancer
    • about 10% have acute pain in the testicle due to rapid tumour growth
  • testicular cancer spreads to retroperitoneal lymph nodes (behind the abdominal cavity) in 10% to 20% of patients and can cause side or back pain; nausea, bloating, or constipation; and enlarged veins in the scrotum
  • testicular cancer that spreads to the lungs can cause breathlessness, cough, chest pain, or haemoptysis
  • in about 2% of people with testicular cancer, breast enlargement occurs

Stage of germ cell testicular tumours at diagnosis (2):

  • stage I (localised to the testicle) in 70% to 75% of patients
  • stage II (metastatic only to the retroperitoneal lymph nodes) in 20%
  • stage III (widely metastatic) in 10%.

Management principles:

  • early diagnosis and treatment, starting with a radical inguinal orchiectomy, are important in optimising outcomes
  • treatment is guided by histology, clinical staging, and risk classification

Prognosis

  • 5-year survival rates are 99%, 92%, and 85% for stages I, II, and III, respectively (2)

References:

  1. Horwich A et al. Testicular germ cell tumour. BMJ. 2013;347:6205.
  2. Singla N, Bagrodia A, Baraban E, Fankhauser CD, Ged YMA. Testicular Germ Cell Tumors: A Review. JAMA. Published online February 03, 2025.
  3. Sohaib SA, Koh DM, Husband JE. The role of imaging in the diagnosis, staging, and management of testicular cancer. AJR Am J Roentgenol. 2008;191(2):387-95.
  4. Voelker R. What Are Testicular Germ Cell Tumors? JAMA. Published online May 29, 2025.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.